FLT3 and acute myeloid leukemia: Despite initial progress with FLT3is, even when combined with cytotoxic drugs, the outcomes of FLT3-ITD AML patients remain unsatisfactory, as these inhibitors primarily slow down the progression of the disease, rather than providing a complete cure [54].